SCHEMBL4283898

SCHEMBL4283898

COc1ccc(C(O)c2c(O)cc(COC(C)=O)cc2OC)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
RORC P51449 3/20 0.42
MAPT P10636 4/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 3/20 0.41
RECQL P46063 1/20 0.41
CYP3A4 P08684 2/20 0.38
PPARG P37231 1/20 0.38
BCHE P06276 1/20 0.38
TYR P14679 1/20 0.38
ACHE P22303 1/20 0.38
CYP19A1 P11511 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4287172 0.88 NPBWR1 (0.41) POLBMEN1KMT2AMAPTMAPK1
SCHEMBL4285592 0.87 POLB (0.39) POLBMEN1KMT2ARORCMAPT
SCHEMBL4292204 0.77 ALDH1A1 (0.40) POLBMEN1KMT2AMAPTMAPK1
SCHEMBL4279701 0.77 CYP3A4 (0.54) MEN1KMT2AMAPTMAPK1CYP3A4
SCHEMBL4291094 0.77 CYP19A1 (0.45) MEN1KMT2AMAPTCYP3A4CYP19A1
SCHEMBL4279556 0.76 POLB (0.39) POLBALDH1A1
SCHEMBL27767699 0.75 NPBWR1 (0.38) MAPTCYP3A4TYRALDH1A1
SCHEMBL4292575 0.75 ALDH1A1 (0.37) POLBMEN1KMT2ARORCMAPT
SCHEMBL13870581 0.74 MET (0.54) MAPK1TDP1CYP3A4NFKB1ALDH1A1
SCHEMBL4281420 0.74 ACACB (0.37) MEN1KMT2ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 POLB 4872/4885MEN1 3776/4885KMT2A 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.